Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
doi:10.1007/s00210-017-1403-2
The Future of Personalized Health Dr
If your COA indicates a different content, your concentration changes
Our objective is to present the pharmacological mechanisms, safety profiles, and regulatory status of prominent approved and unapproved peptides marketed direct to patients, including AOD-9604 (anti-obesity drug 9604), BPC-157 (body protection compound 157), CJC-1295, FS-344 (follistatin-344), GHK-Cu (glycyl-l-histidyl-l-lysine copper), ipamorelin, MOTS-C (mitochondrial ORF of the 12S rRNA type-c), sermorelin, SS-31 (elamipretide), tesamorelin (Egrifta), T4 (thymosin beta-4), and TB-500 (thymosin beta-4 fragment)
INCI Nomenclature: GHK-Cu (glycyl-l-histidyl-l-lysine)
Individuals with severe kidney or liver disease, certain genetic disorders, or those who are pregnant or breastfeeding should avoid glutathione unless cleared by a physician
US$ 23.97
US$ 28.64
US$ 21.39
US$ 23.99